KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
73 hedge funds and large institutions have $493M invested in Kinnate Biopharma Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 15 closing their positions.
Holders
73
Holders Change
-3
Holders Change %
-3.95%
% of All Funds
1.23%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
14
Increased
27
Reduced
13
Closed
15
Calls
$615K
Puts
–
Net Calls
+$615K
Net Calls Change
+$97K